Skip to main content

Best Supportive Care for Palliative Treatment

  • Chapter
  • First Online:
  • 2468 Accesses

Abstract

Head and neck cancer includes epithelial ­malignancies of the upper aerodigestive tract, including the skull base, paranasal sinuses, nasal cavity, oral cavity, naso-, oro- and hypopharynx, larynx and salivary glands, squamous-cell carcinoma being the most prevalent histopathological type. More than 2/3 of patients present at an advanced tumour-stage (III  +  IV UICC) at time of diagnosis. Although much effort has been done in the research of tumour-specific therapy (e.g. new chemotherapy protocols, induction chemotherapy, targeted therapy, intensity-modulated radiotherapy) the overall survival rates have unfortunately not improved. Learning of their cancer diagnosis and receiving tumour-specific treatment has a great impact on individuals living with the disease and their families. Supportive and palliative care is interdisciplinary care and provides support for the physical, emotional and psychological suffering of patients with any advanced illness, regardless of age, diagnosis or life expectancy. The goal is to prevent and relieve suffering and to improve the quality of life for patients. All patients with a cancer diagnosis need general supportive and palliative care, which represents a wide range of services to help the patients to live as actively as possible until death.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Cognetti DM, Weber RS, Lai SY. Head and neck cancer, an ­evolving treatment paradigm. Cancer. 2008;113(7 Suppl):1911–32.

    Article  PubMed  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  3. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systemic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467–75.

    Article  PubMed  CAS  Google Scholar 

  4. Fadul N, Elsayem A, Palmer JL, Del Fabbro E, Swint K, Li Z, et al. Supportive versus palliative care: what’s in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer. 2009;119(9):2013–21.

    Article  Google Scholar 

  5. Morstad Boldt A, Yusuf F, Himelstein B. Perceptions of the term palliative care. J Palliat Med. 2006;5:1128–36.

    Article  Google Scholar 

  6. National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care. 2004. http://www.nationalconsensusproject.org. Accessed 30 March 2008.

  7. Portenoy RK, Miransky J, Thaler HT, et al. Pain in ambulatory patients with lung or colon cancer: Prevalence, characteristics, and effect. Cancer. 1992;70:1616–24.

    Article  PubMed  CAS  Google Scholar 

  8. Payne R, Gonzales GR. Pathophysiology of pain in cancer and other terminal disease. In: Doyle D, Hanks G, Cherny N, et al., editors. Oxford textbook of palliative medicine. 3rd ed. New York: Oxford University Press; 2005. p. 288–98.

    Google Scholar 

  9. Grossmann SA, Sheidler VR, Swedeen K, et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage. 1991;6:53–7.

    Article  Google Scholar 

  10. Agency for Health Care Policy and Research. Cancer Pain Management Panel: Management of Cancer Pain. Washington, DC: U.S. Dept. of Health and Human Services; 1994. Clinical Practice Guidelines Number 9.

    Google Scholar 

  11. Grossman SA, Sheidler VR, McGuire DB, et al. A comparison of the Hopkins pain rating instrument with standard visual analogue and verbal descriptor scales in patients with caner pain. J Pain Symptom Manage. 1992;7(4):196–203.

    Article  PubMed  CAS  Google Scholar 

  12. Schrijvers D. Management of Cancer Pain Professor Session. 2nd European perspectives in head and neck cancer. Prague: Marriott Hotel; 2009.

    Google Scholar 

  13. Cherny NI, Portenoy RK. The management of cancer pain. CA Cancer J Clin. 1994;44:262–303.

    Article  Google Scholar 

  14. Sykes NP. Constipation and diarrhoea. In: Doyle D, Hanks GW, MacDoonald N, editors. Oxford textbook of palliative medicine. New York: Oxford University Press; 1993. p. 299–310.

    Google Scholar 

  15. Campora E, Merlini L, Pace M, et al. The incidence of narcotic-induced emesis. J Pain Symptom Manage. 1991;6:428–30.

    Article  PubMed  CAS  Google Scholar 

  16. Greene WR, Davis WH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J. 1991;84:332–7.

    Article  PubMed  CAS  Google Scholar 

  17. Truog RD, Berde CB, Mitchell C, Greir HE. Barbiturates in the care of the terminally ill. N Engl J Med. 1992;327:1678–82.

    Article  PubMed  CAS  Google Scholar 

  18. Herrstedt J. Prevention and management of mucositis in patients with cancer. Int J Antimicrob Agents. 2000;16:161–3.

    Article  PubMed  CAS  Google Scholar 

  19. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Research and Treatment of Cancer(EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.

    Article  PubMed  CAS  Google Scholar 

  20. Bourhis J, Etessami A, Lusinchi A. New trend in radiotherapy for head and neck cancer. Ann Oncol. 2005;16 Suppl 2:ii255–7.

    Article  PubMed  Google Scholar 

  21. Archibald D, Lockhart PB, Sonis ST, et al. Oral complications of multimodality therapy for advanced squamous cell carcinoma of head and neck. Oral Surg Oral Med Oral Pathol. 1986;61:139–41.

    Article  PubMed  CAS  Google Scholar 

  22. Sciubba JJ, Goldenber G. Oral complications of radiotherapy. Lancet Oncol. 2006;7:175–83.

    Article  PubMed  Google Scholar 

  23. Brizel D, Overgaard J. Does amifostine have a role in chemoradiation treatment? Lancet Oncol. 2003;4:378–81.

    Article  PubMed  CAS  Google Scholar 

  24. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351:2590–8.

    Article  PubMed  CAS  Google Scholar 

  25. Stiff PJ, Emmanouilides C, Bensinger WI, et al. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. J Clin Oncol. 2006;24(33):5186–93.

    Article  PubMed  CAS  Google Scholar 

  26. Chambers MS. Radiation-induced xerostomia. Head Neck. 2007;29:58–63.

    Article  PubMed  Google Scholar 

  27. Wescott WB. Alterations in whole saliva flow rate induced by fractionated radiotherapy. AJR Am J Roentgenol. 1978;130(1):145–9.

    PubMed  CAS  Google Scholar 

  28. Keilbasa AM, Hinkelbein W, Hellwig E, Meyer-Lückel H. Radiation-related damage to dentition. Lancet Oncol. 2006;7:326–35.

    Article  Google Scholar 

  29. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Bil Phys. 2001;50:695–704.

    Article  CAS  Google Scholar 

  30. Roesink JM, Konings AW, Terhaard CH, et al. Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: radiation dose dependency and compensatory mechanisms. Int J Radiat Oncol Biol Phys. 1999;45:483–9.

    Article  PubMed  CAS  Google Scholar 

  31. Vissink A, Johannes’s-Gravenmade E, Panders AK, Vermey A. Treatment of hyposalivation. Ear Nose Throat J. 1988;67:179–85.

    PubMed  CAS  Google Scholar 

  32. Dirix P, Nuyts S, Walter Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer. Cancer. 2006;107:2525–34.

    Article  PubMed  Google Scholar 

  33. Morrow SG. Mechanism and management of chemotherapy-induced nausea and vomiting. Blood Rev. 1987;1:50–7.

    Article  Google Scholar 

  34. Bakowski MT. Advances in anti-emetic therapy. Cancer Treat Rev. 1984;11:237–56.

    Article  PubMed  CAS  Google Scholar 

  35. Kaye SB. How should nausea be assessed in patients receiving chemotherapy? Cancer Treat Rev. 1991;1:85–93.

    Article  Google Scholar 

  36. Wilcox PM, Fetting JH, Nettesheim KM, Abeloff MD. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep. 1982;66:1601–4.

    PubMed  CAS  Google Scholar 

  37. Dodds LJ. The control of cancer chemotherapy-induced nausea and vomiting. J Clin Hosp Pharm. 1985;10(2):143–66.

    PubMed  CAS  Google Scholar 

  38. Wickham R. Managing chemotherapy-related nausea and vomiting: the state of the art. Oncol Nurs Forum. 1989;16:563–74.

    PubMed  CAS  Google Scholar 

  39. Coons HL, Levanthal H, Nerenz DR, Love RR, Larson S. Anticipatory nausea and emotional distress in patients receiving cisplatin-based chemotherapy. Oncol Nurs Forum. 1987;14(4):31–5.

    PubMed  CAS  Google Scholar 

  40. Morrow GR. Chemotherapy-related nausea and vomiting: etiology and management. Cancer J Clin. 1989;39:89–104.

    Article  CAS  Google Scholar 

  41. Gralla RJ, Tyson LB, Kris MG, Clark RA. The management of chemotherapy-induced nausea and vomiting. Med Clin North Am. 1987;71(2):289–301.

    PubMed  CAS  Google Scholar 

  42. Andrykowski MA. Definitional issues in the study of anticipatory nausea in cancer chemotherapy. J Behav Med. 1986;9:33–41.

    Article  PubMed  CAS  Google Scholar 

  43. ASCO Patient Guide. 2006 http://www.asco.org/ASCOv2/Press+Center/Latest+News+Releases/ASCO+Releases+Updated+Clinical+Practice+Guideline+on+the+Use+of+Antiemetics+for+Cancer+Patients. Accessed 20 July 2009.

  44. Inui A. Cancer anorexia-cachexia syndrome. CA Cancer J Clin. 2002;52:72–91.

    Article  PubMed  Google Scholar 

  45. Bruera E, Sweeney C. Cachexia and asthenia in cancer patients. Lancet Oncol. 2000;1:138–47.

    Article  PubMed  CAS  Google Scholar 

  46. Newman LA, Vierra F, Schwiezer V, et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998;124:589–92.

    PubMed  CAS  Google Scholar 

  47. Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 1996;106:1157–66.

    Article  PubMed  CAS  Google Scholar 

  48. Chonchinov HM. Depression in cancer patients. Lancet Oncol. 2001;2:499–505.

    Article  Google Scholar 

  49. Nauck F, Al-Epping B. Crises in palliative care – a comprehensive approach. Lancer Oncol. 2008;9:1086–91.

    Article  Google Scholar 

  50. Ciais JF, Pradier C, Ciais C, et al. Impact of a hospice home team on unwanted hospitalisation of terminally-ill patients at home in acute medical emergencies. Presse Méd. 2007;36:404–9.

    Article  PubMed  Google Scholar 

  51. Klocker JG, Klocker-Kaiser U, Schwaninger M. Truth in the relationship between cancer patient and physician. Ann N Y Acad Sci. 1997;809:56–65.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michaela Salzwimmer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Salzwimmer, M. (2011). Best Supportive Care for Palliative Treatment. In: Bernier, J. (eds) Head and Neck Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9464-6_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9464-6_48

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9463-9

  • Online ISBN: 978-1-4419-9464-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics